Beyond mainstream: Making the case for fecal bacteriotherapy
Frank Myers MA, CIC

December 2011 
Volume 41  Number 12
Pages 50 - 53
  PDF Version Available!

FECAL TRANSPLANT, also known as fecal bacteriotherapy, is probably the most headline-grabbing treatment of Clostridium difficile-associated disease (CDAD). Building on the approach of probiotics, fecal bacteriotherapy entails using feces as medicine. Although doing so goes against most of western medicine's basic tenets, experts in infectious diseases and gastroenterology find merit in the procedure. In fact, at the 48th Annual Meeting of the Infectious Diseases Society of America, two leaders in the field of CDAD debated not on whether to do fecal transplant, but how...and in what circumstances.1Fecal bacteriotherapy targets bacterial interference within the bowel. C. difficile, an anaerobic, Gram-positive, spore-forming bacillus, invades and colonizes the gastrointestinal tract. Infection may precede or proceed gut insult from events such as antibiotic therapy or chronic Salmonella infection. In cases of chronic C. difficile, mainstream therapy usually fails and the patient experiences recurrent diarrhea, abdominal pain, nausea, vomiting, and bowel inflammation. Introducing normal bacterial flora from a healthy donor allows the patient's colon to recolonize with positive bacterial flora.To date, there have been just over 350 fecal transplants to treat CDAD.2 The first reported procedure for recurrent infection was published in U.S. medical literature in 2003, just as C. difficile illness rates were increasing, along with the strain's pathogenicity. In this study, 18 subjects had the feces administered through a nasogastric tube.3 Now, most fecal transplants (80%) are administered through colon oscopy. No randomized control trial comparing the two methods of administration has been conducted and published, but reported outcomes appear similar. Note, though, that methodological differences and patient selection criteria prevent either approach from claiming treatment rates as comparable, superior, or inferior to the other approach.Some clinicians claim that colon oscopy

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95

The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95

Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.

Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.

Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events